Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03945435 · ClinicalTrials.gov registry record

Mechanisms of Exercise Resistance in Metabolic Disease

A clinical trial, sponsored by Joslin Diabetes Center.

Completed
Registry status
29
Enrollment target

NCT03945435: Completed study, sponsored by Joslin Diabetes Center.

NCT03945435 is a clinical trial that has completed, run by Joslin Diabetes Center. The registered enrollment target is 29 participants. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03945435 has completed, sponsored by Joslin Diabetes Center.

COMPLETED
Registry status
29 participants
Enrollment target

Study Summary

This project will determine exercise capacity and molecular markers of the response to acute exercise in human subjects with impaired or normal glucose tolerance.

Primary Outcome

Cardiorespiratory Fitness

Trial Details

FieldValue
Enrollment Target 29 participants
Start Date 2018-07-01
Est. Completion 2019-04-11
Joslin Diabetes Center

73 total trials

What the finished NCT03945435 record still lists

NCT03945435 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 29 participants, a relatively small participant target.

The record links to 0 conditions, and to 0 interventions.

NCT03945435 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT03945435 about?

NCT03945435 is a clinical study titled "Mechanisms of Exercise Resistance in Metabolic Disease". This project will determine exercise capacity and molecular markers of the response to acute exercise in human subjects with impaired or normal glucose tolerance.

What is the current status of trial NCT03945435?

This trial is currently completed. The enrollment target is 29 participants. The study started on 2018-07-01. Estimated completion is 2019-04-11.

Who is sponsoring clinical trial NCT03945435?

This trial is sponsored by Joslin Diabetes Center, which has 73 total clinical trials registered on ClinicalTrials.gov.

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT02429557 · 29 participants · Phase 1

    Hemodynamic Mechanisms of Abdominal Compression in the Treatment of Orthostatic Hypotension in Autonomic Failure

  • NCT02568878 · 29 participants · Phase 3

    Creatine for Depressed Male and Female Methamphetamine Users

  • NCT03014401 · 29 participants · NA

    The Effect of Adipose-Derived Stem Cells for Knee Osteoarthritis

  • NCT03128996 · 29 participants · Phase 1

    Reduced Intensity Conditioning and Familial HLA-Mismatched BMT for Non-Malignant Disorders

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT03945435, the US trial registry maintained by the National Library of Medicine. NCT03945435 (small enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.